Overview of Cost Analyses of mCME v2.0 Program for HIV Clinicians in Vietnam
| Cost Analysis | Description |
|---|---|
| Financial analysis | An analysis calculating the total financial expenditures associated with the 13-month research study. |
| Economic analysis | An analysis of the total economic costs (i.e., resource costs) for the 13-month research study, including volunteer time, travel not paid for by the study, and pre-developed infrastructure that was required for the intervention (i.e., online courses). |
| Financial cost-effectiveness analysis | An analysis calculating the incremental financial cost-effectiveness ratio, which was estimated by the difference in total financial costs between intervention and control groups, respectively, divided by the change in online course visits and endline exam scores for clinicians in the intervention and control groups, respectively. |
| Economic cost-effectiveness analysis | An analysis calculating the incremental economic cost-effectiveness ratio, which was estimated by the difference in total economic costs between intervention and control groups, respectively, divided by the change in online course visits and endline exam scores for clinicians in the intervention and control groups, respectively. |
| Forecasted analysis | An analysis designed to assist policy making related to CME: this involved estimating the costs of a future scaled-up program to all HIV clinicians in Vietnam (N=865). We estimated economic costs over 2 alternative time frames: a 9-month period (January 2021 to September 2021) and a 10-year period (January 2021 to January 2031). |
Abbreviations: CME, continuing medical education; mCME, SMS-based CME.